Established in 1976, J.B.Chemicals & Pharmaceuticals Ltd. (JBCPL) is one of India’s fastest growing pharmaceutical companies. An integrated, research-oriented, public listed organisation with a focus on supplying affordable, quality products both in India and International markets, JBCPL is trusted by healthcare professionals globally.

JBCPL is widely committed to manufacturing a range of innovative specialty products that include various pharmaceutical dosage forms like tablets, injectable (vials, ampoules, form fill seal), creams & ointments, lozenges, herbal liquids and capsules. In India and International markets, JBCPL is also known as Unique Pharmaceutical Laboratories and is a division of JBCPL.

JBCPL exports too many countries worldwide with presence in US, Europe, Australia, South Africa, other developing countries, Russia and CIS. The Company continues to invest in growing its share in the regulated markets such as USA, Europe and Australia. JBCPL has a strong R&D and regulatory set-up for development of new drug delivery system and formulations, filing of ANDAs and DMFs. Its state-of-the-art manufacturing facilities are approved by health authorities of key regulated markets.

Business area of the company

J. B. Chemicals & Pharmaceuticals is engaged in the business of manufacturing and marketing of diverse range of pharmaceutical formulations, herbal remedies and APIs.

JB Chemicals & Pharmaceuticals Ltd.

Ajanta Pharma Ltd.

Sanofi India Ltd.

Glenmark Pharmaceuticals Ltd.

Suven Pharmaceuticals Ltd.

Alembic Pharmaceuticals Ltd.

Natco Pharma Ltd.

Piramal Enterprises Ltd.

Pfizer Ltd.

Eris Lifesciences Ltd.

Ipca Laboratories Ltd.

Glaxosmithkline Pharmaceuticals Ltd.

Granules India Ltd.

Astrazeneca Pharma India Ltd.

Laurus Labs Ltd.

HDFC Bank Ltd.

ICICI Bank Ltd.

ITC Ltd.

Reliance Industries Ltd.

Tata Motors Ltd.

Market Cap	15,470 Cr		EPS	46.1		High	2030
Stock P/E	43.4		Net Profit Margin	13.7		Low	1995.5

Market Cap	15,470 Cr	ROE	19.9%
P/E Ratio(TTM)	43.4	EPS(TTM)	48.0
P/B Ratio	6.8	Dividend Yield	0.8%
Industry P/E	65.9	Book Value	294.1
		Face Value	2.0

JBCHEPHARM